KDM1A and central nervous system cancer: As we have seen through this review, multiple epigenetic activities can be involved in glioma malignancy in a complex manner; therefore, the simultaneous modulation of various epigenetic activities may be highly effective, as demonstrated by the dual inhibition of HDACs and KDM1A/LSD1 (87, 88).